• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Delta 变异株在一艘液化天然气(LNG)船舶上的暴发,以及疫苗效力的评估。

Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectiveness.

机构信息

Central Queensland Public Health Unit, Central Queensland Hospital and Health Service, Rockhampton, Australia.

COVID Incident Management Team, COVID Public Health Response Division, Queensland Health, Australia.

出版信息

Commun Dis Intell (2018). 2022 Aug 18;46. doi: 10.33321/cdi.2022.46.40.

DOI:10.33321/cdi.2022.46.40
PMID:35981815
Abstract

In August 2021, there was an outbreak of severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) Delta variant on an international liquified natural gas (LNG) vessel offshore to Gladstone, Queensland. Fourteen of the 26 crew members aboard the vessel tested positive for SARS-COV-2 on PCR during the outbreak. Vaccine effectiveness (VE) was 52% for all lab-confirmed SARS-CoV-2 infections, 65% for symptomatic SARS-CoV-2 infection and 100% for severe SARS-CoV-2. The attack rate (AR) of SARS-CoV-2 Delta variant was 54% (14/26). With heightened public health measures and infection control practices, we were able to declare the outbreak over in 26 days.

摘要

2021 年 8 月,在昆士兰州格拉德斯通近海的一艘国际液化天然气(LNG)船上爆发了严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)Delta 变体。在疫情爆发期间,船上的 26 名船员中有 14 人经 PCR 检测对 SARS-CoV-2 呈阳性。疫苗有效性(VE)对所有实验室确诊的 SARS-CoV-2 感染为 52%,对有症状的 SARS-CoV-2 感染为 65%,对严重的 SARS-CoV-2 感染为 100%。SARS-CoV-2 Delta 变体的发病率(AR)为 54%(14/26)。通过加强公共卫生措施和感染控制措施,我们能够在 26 天内宣布疫情结束。

相似文献

1
Outbreak of SARS-CoV-2 Delta variant on a single liquified natural gas (LNG) vessel, with estimates of vaccine effectiveness.Delta 变异株在一艘液化天然气(LNG)船舶上的暴发,以及疫苗效力的评估。
Commun Dis Intell (2018). 2022 Aug 18;46. doi: 10.33321/cdi.2022.46.40.
2
Investigation of a Severe Acute Respiratory Syndrome Coronavirus 2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis: Maricopa County, Arizona, June-July 2021.对亚利桑那州马里科帕县一家熟练护理机构居民中严重急性呼吸综合征冠状病毒 2 型 delta(B.1.617.2)变异株爆发的调查及疫苗有效性分析:2021 年 6 月至 7 月。
Clin Infect Dis. 2022 Aug 24;75(1):e20-e26. doi: 10.1093/cid/ciac240.
3
Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.mRNA BNT162b2 新冠疫苗在法国南部长期护理机构老年居民中预防 SARS-CoV-2 德尔塔变异株的有效性,2021 年 5 月。
Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2586-2591. doi: 10.26355/eurrev_202204_28496.
4
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2(Delta)变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络,2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
5
Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study.在广州,灭活的 SARS-CoV-2 疫苗对 Delta 变异株感染的有效性:一项病例对照的真实世界研究。
Emerg Microbes Infect. 2021 Dec;10(1):1751-1759. doi: 10.1080/22221751.2021.1969291.
6
Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.高度接种疫苗的澳大利亚人群在 SARS-CoV-2 德尔塔疫情期间的疫苗突破性感染。
Commun Dis Intell (2018). 2022 Jun 23;46. doi: 10.33321/cdi.2022.46.32.
7
Pens down: An outbreak of the B.1.617.2 SARS-CoV-2 variant in an Australian high school, August 2021.笔停:2021 年 8 月,澳大利亚一所高中爆发 B.1.617.2 型 SARS-CoV-2 变异株疫情。
Commun Dis Intell (2018). 2022 Jul 21;46. doi: 10.33321/cdi.2022.46.44.
8
Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021.疫苗对 2021 年 4 月美国华盛顿护理机构居民中 SARS-CoV-2 变体 P.1 的有效性。
Emerg Infect Dis. 2022 Nov;28(11):2338-2341. doi: 10.3201/eid2811.221043. Epub 2022 Sep 28.
9
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.在德尔塔和奥密克戎变异株流行期间,mRNA 疫苗加强针在成年人中的 COVID-19 相关急诊和紧急护理就诊和住院方面的效果 - VISION 网络,10 个州,2021 年 8 月至 2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
10
Hospital outbreak of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant in partially and fully vaccinated patients and healthcare workers in Toronto, Canada.加拿大多伦多部分和完全接种疫苗的患者和医护人员中严重急性呼吸冠状病毒 2 型(SARS-CoV-2)德尔塔变异株引发的医院疫情。
Infect Control Hosp Epidemiol. 2023 Feb;44(2):328-331. doi: 10.1017/ice.2021.471. Epub 2021 Oct 28.